A citation-based method for searching scientific literature

Narayanam V Rao, Brian Argyle, Xiaoyu Xu, Paul R Reynolds, Jeanine M Walenga, Margaret Prechel, Glenn D Prestwich, Robert B MacArthur, Bradford B Walters, John R Hoidal, Thomas P Kennedy. Am J Physiol Cell Physiol 2010
Times Cited: 104







List of co-cited articles
957 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung.
A Fryer, Y C Huang, G Rao, D Jacoby, E Mancilla, R Whorton, C A Piantadosi, T Kennedy, J Hoidal. J Pharmacol Exp Ther 1997
95
18


2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation.
Kathryn L Griffin, Bernard M Fischer, Apparao B Kummarapurugu, Shuo Zheng, Thomas P Kennedy, Narayanam V Rao, W Michael Foster, Judith A Voynow. Am J Respir Cell Mol Biol 2014
34
38


RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
Khin-Mar Myint, Yasuhiko Yamamoto, Toshio Doi, Ichiro Kato, Ai Harashima, Hideto Yonekura, Takuo Watanabe, Harumichi Shinohara, Masayoshi Takeuchi, Koichi Tsuneyama,[...]. Diabetes 2006
200
9


Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH).
M V Joglekar, P M Quintana Diez, S Marcus, R Qi, B Espinasse, M R Wiesner, E Pempe, J Liu, D M Monroe, G M Arepally. Thromb Haemost 2012
24
37

2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity.
Shuo Zheng, Apparao B Kummarapurugu, Daniel K Afosah, Nehru Viji Sankaranarayanan, Rio S Boothello, Umesh R Desai, Thomas Kennedy, Judith A Voynow. Am J Respir Cell Mol Biol 2017
18
50

Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
D J Tyrrell, A P Horne, K R Holme, J M Preuss, C P Page. Adv Pharmacol 1999
159
8


Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.
A Taguchi, D C Blood, G del Toro, A Canet, D C Lee, W Qu, N Tanji, Y Lu, E Lalla, C Fu,[...]. Nature 2000
8

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
M Neeper, A M Schmidt, J Brett, S D Yan, F Wang, Y C Pan, K Elliston, D Stern, A Shaw. J Biol Chem 1992
8

Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.
Joyce N Gonzales, Kyung-mi Kim, Marina A Zemskova, Ruslan Rafikov, Brenten Heeke, Matthew N Varn, Stephen Black, Thomas P Kennedy, Alexander D Verin, Evgeny A Zemskov. Vascul Pharmacol 2014
25
32



Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation.
R M Nelson, O Cecconi, W G Roberts, A Aruffo, R J Linhardt, M P Bevilacqua. Blood 1993
463
7


The receptor for advanced glycation end products (RAGE) and the lung.
Stephen T Buckley, Carsten Ehrhardt. J Biomed Biotechnol 2010
165
7

HMGB1 and RAGE in inflammation and cancer.
Gary P Sims, Daniel C Rowe, Svend T Rietdijk, Ronald Herbst, Anthony J Coyle. Annu Rev Immunol 2010
991
7

Structural basis for ligand recognition and activation of RAGE.
Michael Koch, Seth Chitayat, Brian M Dattilo, Andre Schiefner, Joachim Diez, Walter J Chazin, Günter Fritz. Structure 2010
171
7


RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.
Louis J Sparvero, Denise Asafu-Adjei, Rui Kang, Daolin Tang, Neilay Amin, Jaehyun Im, Ronnye Rutledge, Brenda Lin, Andrew A Amoscato, Herbert J Zeh,[...]. J Transl Med 2009
390
7

RAGE: a single receptor fits multiple ligands.
Günter Fritz. Trends Biochem Sci 2011
213
7

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.
S D Yan, X Chen, J Fu, M Chen, H Zhu, A Roher, T Slattery, L Zhao, M Nagashima, J Morser,[...]. Nature 1996
7

Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro.
Yan Ling, Zhi-Yong Yang, Tao Yin, Li Li, Wei-Wei Yuan, He-Shui Wu, Chun-You Wang. Int Immunopharmacol 2011
31
22

Heparin-protein interactions.
Ishan Capila, Robert J Linhardt. Angew Chem Int Ed Engl 2002
7

Partially-desulfated heparin improves survival in Pseudomonas pneumonia by enhancing bacterial clearance and ameliorating lung injury.
Lokesh Sharma, Jiao Wu, Vivek Patel, Ravikumar Sitapara, Narayanam V Rao, Thomas P Kennedy, Lin L Mantell. J Immunotoxicol 2014
18
38

Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis.
Apparao B Kummarapurugu, Daniel K Afosah, Nehru Viji Sankaranarayanan, Rahaman Navaz Gangji, Shuo Zheng, Thomas Kennedy, Bruce K Rubin, Judith A Voynow, Umesh R Desai. J Biol Chem 2018
24
29

Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma.
Z Diamant, M C Timmers, H van der Veen, C P Page, F J van der Meer, P J Sterk. Am J Respir Crit Care Med 1996
103
6



Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
Jingjing Xie, Sergey Reverdatto, Andrej Frolov, Ralf Hoffmann, David S Burz, Alexander Shekhtman. J Biol Chem 2008
175
6

RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells.
Paul R Reynolds, Stephen D Kasteler, Manuel G Cosio, Anne Sturrock, Tom Huecksteadt, John R Hoidal. Am J Physiol Lung Cell Mol Physiol 2008
83
7


Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea.
Jianxing Zhang, Xiaoyu Xu, Narayanam V Rao, Brian Argyle, Lindsi McCoard, William J Rusho, Thomas P Kennedy, Glenn D Prestwich, Gerald Krueger. PLoS One 2011
55
10

Proteases and cystic fibrosis.
Judith A Voynow, Bernard M Fischer, Shuo Zheng. Int J Biochem Cell Biol 2008
135
6

Risk factors for bronchiectasis in children with cystic fibrosis.
Peter D Sly, Catherine L Gangell, Linping Chen, Robert S Ware, Sarath Ranganathan, Lauren S Mott, Conor P Murray, Stephen M Stick. N Engl J Med 2013
378
6

Receptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammation.
Paul R Reynolds, Stephen D Kasteler, Robert E Schmitt, John R Hoidal. Am J Respir Cell Mol Biol 2011
59
8

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
Angela Raucci, Simona Cugusi, Antonella Antonelli, Silvia M Barabino, Lucilla Monti, Angelika Bierhaus, Karina Reiss, Paul Saftig, Marco E Bianchi. FASEB J 2008
433
5

Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Nassima Ferhani, Séverine Letuve, Alexander Kozhich, Olivier Thibaudeau, Martine Grandsaigne, Marielle Maret, Marie-Christine Dombret, Gary P Sims, Roland Kolbeck, Anthony J Coyle,[...]. Am J Respir Crit Care Med 2010
172
5

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment.
Triantafyllos Chavakis, Angelika Bierhaus, Nadia Al-Fakhri, Darius Schneider, Steffen Witte, Thomas Linn, Mariko Nagashima, John Morser, Bernd Arnold, Klaus T Preissner,[...]. J Exp Med 2003
467
5

More to "heparin" than anticoagulation.
U Lindahl, K Lidholt, D Spillmann, L Kjellén. Thromb Res 1994
309
5

Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.
V H Thourani, S S Brar, T P Kennedy, L R Thornton, J A Watts, R S Ronson, Z Q Zhao, A L Sturrock, J R Hoidal, J Vinten-Johansen. Am J Physiol Heart Circ Physiol 2000
69
7

Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.
Henri J Huttunen, Carole Fages, Juha Kuja-Panula, Anne J Ridley, Heikki Rauvala. Cancer Res 2002
227
5

Embryonic overexpression of receptors for advanced glycation end-products by alveolar epithelium induces an imbalance between proliferation and apoptosis.
Jeffrey A Stogsdill, Megan P Stogsdill, Jason L Porter, Joshua M Hancock, Adam B Robinson, Paul R Reynolds. Am J Respir Cell Mol Biol 2012
28
17

Understanding RAGE, the receptor for advanced glycation end products.
Angelika Bierhaus, Per M Humpert, Michael Morcos, Thoralf Wendt, Triantafyllos Chavakis, Bernd Arnold, David M Stern, Peter P Nawroth. J Mol Med (Berl) 2005
905
5

Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis.
Theodore G Liou, Frederick R Adler, Ruth H Keogh, Yanping Li, Judy L Jensen, William Walsh, Kristyn Packer, Teresa Clark, Holly Carveth, Jun Chen,[...]. PLoS One 2012
45
11

Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Annamaria Naggi, Benito Casu, Marta Perez, Giangiacomo Torri, Giuseppe Cassinelli, Sergio Penco, Claudio Pisano, Giuseppe Giannini, Rivka Ishai-Michaeli, Israel Vlodavsky. J Biol Chem 2005
177
5

Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
Sinéad Weldon, Paul McNally, Noel G McElvaney, J Stuart Elborn, Danny F McAuley, Julien Wartelle, Abderrazzaq Belaaouaj, Rodney L Levine, Clifford C Taggart. J Immunol 2009
86
5

Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemia.
Tibor J Kovacsovics, Alice Mims, Mohamed E Salama, Jeremy Pantin, Narayanam Rao, Ken M Kosak, Peter Ahorukomeye, Martha J Glenn, Michael W N Deininger, Kenneth M Boucher,[...]. Blood Adv 2018
35
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.